Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Othman

Showing results (211-220 of 477) with videos related to

Pageof 48
Sort By:
The AAPS Journal|July 7, 2007
Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemateAhmed A Othman, David M Tenero, Duane A Boyle, et al.
BMC Microbiology|April 26, 2023
Biocontrol of multi-drug resistant pathogenic bacteria in drainage water by locally isolated bacteriophageRabab M Soliman, Badawi A Othman, Sahar A Shoman, et al.
Cureus|November 24, 2025
Optimizing Venous Thromboembolism Prophylaxis in Achilles Tendon Rupture: A Systematic Review of Current Evidence and Protocol RecommendationsMohamed Hashem, Mohamed Elbeshbeshy, Mohamed Khalafallah, et al.
British Journal of Pharmacology|July 12, 2011
The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphineDaniel T Baptista-Hon, Tarek Z Deeb, Nidaa A Othman, et al.
Journal of Clinical Pharmacology|May 25, 2010
Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteersAhmed A Othman, Robert A Lenz, Jun Zhang, et al.
Schizophrenia Bulletin|February 12, 2014
A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophreniaGeorge M Haig, Earle Bain, Weining Robieson, et al.
Journal of Spine Surgery (Hong Kong)|August 6, 2019
Current state of minimally invasive spine surgeryAvani S Vaishnav, Yahya A Othman, Sohrab S Virk, et al.
Scientific Reports|December 5, 2024
Impact of associated factors and adherence to Mediterranean diet on insomnia among Arab men living in JordanIman F Mahmoud, Khadejah F Mahmoud, Nour A Elsahoryi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 18, 2023
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, <i>in vitro</i> and <i>in silico</i> studiesDina I A Othman, Abdelrahman Hamdi, Samar S Tawfik, et al.
Journal of Helminthology|February 14, 2013
Interactions between Trichinella spiralis infection and induced colitis in miceD S Ashour, A A Othman, M M Shareef, et al.
Pageof 48

Showing results (211-220 of 477) with videos related to

Sort By:
Pageof 48
The AAPS Journal|July 7, 2007
Population pharmacokinetics of S(-)-carvedilol in healthy volunteers after administration of the immediate-release (IR) and the new controlled-release (CR) dosage forms of the racemateAhmed A Othman, David M Tenero, Duane A Boyle, et al.
BMC Microbiology|April 26, 2023
Biocontrol of multi-drug resistant pathogenic bacteria in drainage water by locally isolated bacteriophageRabab M Soliman, Badawi A Othman, Sahar A Shoman, et al.
Cureus|November 24, 2025
Optimizing Venous Thromboembolism Prophylaxis in Achilles Tendon Rupture: A Systematic Review of Current Evidence and Protocol RecommendationsMohamed Hashem, Mohamed Elbeshbeshy, Mohamed Khalafallah, et al.
British Journal of Pharmacology|July 12, 2011
The 5-HT3B subunit affects high-potency inhibition of 5-HT3 receptors by morphineDaniel T Baptista-Hon, Tarek Z Deeb, Nidaa A Othman, et al.
Journal of Clinical Pharmacology|May 25, 2010
Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteersAhmed A Othman, Robert A Lenz, Jun Zhang, et al.
Schizophrenia Bulletin|February 12, 2014
A randomized trial of the efficacy and safety of the H3 antagonist ABT-288 in cognitive impairment associated with schizophreniaGeorge M Haig, Earle Bain, Weining Robieson, et al.
Journal of Spine Surgery (Hong Kong)|August 6, 2019
Current state of minimally invasive spine surgeryAvani S Vaishnav, Yahya A Othman, Sohrab S Virk, et al.
Scientific Reports|December 5, 2024
Impact of associated factors and adherence to Mediterranean diet on insomnia among Arab men living in JordanIman F Mahmoud, Khadejah F Mahmoud, Nour A Elsahoryi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|January 18, 2023
Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition, <i>in vitro</i> and <i>in silico</i> studiesDina I A Othman, Abdelrahman Hamdi, Samar S Tawfik, et al.
Journal of Helminthology|February 14, 2013
Interactions between Trichinella spiralis infection and induced colitis in miceD S Ashour, A A Othman, M M Shareef, et al.
Pageof 48